ERBB2 and neoplasm: Meta-analyses and systematic reviews have shown that numerous factors—including age, genetic polymorphisms, tumor-infiltrating lymphocytes, programmed death-ligand 1, ER, progesterone receptor, and HER2 expression status—may be predictive of response to NAC in women with breast cancer7,40–42.